Nasal desmopressin (DDAVP, Stimate, etc) is no longer approved for bedwetting

See updated information on this topic from Health Canada

Nasal desmopressin (DDAVP, Stimate, etc) is no longer approved for bedwetting...due to reports of serious hyponatremia.

Most of these cases occur in children using the nasal formulations for bedwetting...probably because dosing errors are more common with the nasal form than the tablets.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote